Ole Per Maloy – CEO, Siemens Healthineers, Middle East and Southern & Eastern Africa

20.10.2021
Siemens Healthineers’ CEO for the Middle East and Southern and Eastern Africa, Ole Per Maloy, outlines the company’s different business models in the region, how it chooses partners in markets where Siemens Healthineers previously operated indirectly, and explains how the Varian acquisition will allow the organisation to provide comprehensive cancer solutions.  
We have the potential to make significant contributions to Saudi’s Vision 2030 because of our extensive portfolio and capabilities in artificial intelligence (AI) and IT solutions that can connect hospitals and connect rural healthcare institutions with diagnostic centres
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In
Tags:
Saudi Arabia, Siemens Healthineers, MEA, Medtech

Related Interviews

Mohamed Mazen Batterjee – Managing Director, Batterjee Pharma

Mohamed Mazen Batterjee, managing director of Batterjee Pharma, explains how he has turned the business around since joining in 2014, the interplay between the firm’s contract and proprietary manufacturing operations,…

Rami Rajab – Chairman, Mecomed

Mecomed is the largest medical devices, imaging, and diagnostics trade association in the Middle East and Africa (MEA). Rami Rajab, chairman, highlights the role of the association in shaping the…

Mohamed Mostafa – Vice President and General Manager Saudi Arabia &…

IQVIA Vice President and General Manager Saudi Arabia & Egypt Mohamed Mostafa gives his expert insights into the transformation of the Saudi pharma market in recent years, covering everything from…

Related Articles

Company Spotlight / Saudi Chemical Company Holding: At the Forefront of Saudi Healthcare’s Evolution

Saudi Chemical Company Holding (SCCH), Saudi Arabia’s leading manufacturer of civil and military explosives, has been expanding its pharma sector footprint in recent years. Today, the company has capabilities across…

Pharma Faces / Mohammed Nasser, Amgen MEA

Seasoned executive Mohamed Nasser currently oversees 16 markets for Amgen across the MEA region, including its most important – Saudi Arabia. He shares some of the key skills that pharma…

Saudi Arabia / IP: Room for Improvement?

While Saudi Arabia is becoming an increasingly attractive investment destination for global pharma, some stakeholders continue to have concerns about whether the country’s intellectual property (IP) protection system is truly…

Latest Report

Saudi Arabia Pharma Report 2022

Related Content

Saudi Arabia
Siemens Healthineers
MEA
Medtech